2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
First Claim
Patent Images
1. A pharmaceutical composition comprising a compound of the formula:
0 Assignments
0 Petitions
Accused Products
Abstract
Novel compounds selected from 2-(3-aminoaryl)amino-4-aryl-thiazoles of formula (I) that selectively modulate, regulate, and/or inhibit signal transductions mediated by certain native and/or mutant tyrosine kinases implicated in a variety of human and animal diseases such as cell proliferative metabolic, allergic and degenerative disorders. More particularly, these compounds are potent and selective c-kit inhibitors.
40 Citations
10 Claims
- 1. A pharmaceutical composition comprising a compound of the formula:
- 5. An oral pharmaceutical composition comprising 4-(4-methyl-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-thiazol-2-ylamino)-phenyl]-benzamide:
Specification